tradingkey.logo
tradingkey.logo
Search

TG Therapeutics Inc

TGTX
Add to Watchlist
58.110USD
+0.950+1.66%
Close 09-22 16:00ET
8.90BMarket Cap
18.15P/E TTM
Pre-market 04:36 (ET)58.300USD+0.190+0.33%

TG Therapeutics Inc (TGTX) Revenue Performance

Updated: Mar 31, 2026

By Business

Annual
Annual
Quarterly
Total product revenue, net
Royalty Revenue
Other Revenue
License Revenue
Milestone Revenue
FY2025
FY2024
Total product revenue, net
606.93M(98.48%)
313.73M(95.36%)
Royalty Revenue
5.62M(0.91%)
801.00K(0.24%)
Other Revenue
3.59M(0.58%)
1.82M(0.55%)
License Revenue
152.00K(0.02%)
152.00K(0.05%)
Milestone Revenue
--(--)
12.50M(3.80%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.